Unique ID issued by UMIN | UMIN000030562 |
---|---|
Receipt number | R000034885 |
Scientific Title | The natural history study of ambulatory patients with Duchenne muscular dystrophy |
Date of disclosure of the study information | 2017/12/25 |
Last modified on | 2024/06/30 12:59:47 |
The natural history study of ambulatory patients with Duchenne muscular dystrophy
NH-ambulatory DMD
The natural history study of ambulatory patients with Duchenne muscular dystrophy
NH-ambulatory DMD
Japan |
Duchenne muscular dystrophy
Neurology | Pediatrics | Rehabilitation medicine |
Others
NO
To investigate the natural history data of motor function in ambulatory patients with Duchenne muscular dystrophy (DMD) receiving standard care in Japan until they become non-ambulatory.
Others
This study is aimed to select avairable outcome measure of motor function test for drug development of DMD in the future.
Others
Others
Not applicable
Motor function test
Activities of daily living (ADL)
Patient reported outcome (PRO)
Acceleration meter/activity meter
Subject demographics
Observational
5 | years-old | <= |
Not applicable |
Male
1) Patients with a dystrophin abnormality proven by dystrophin gene testing or muscle pathology and a definitive diagnosis of DMD
2) Sex: male
3) Aged 5 or older (at the time of informed consent)
4) Able to rise from the floor and walk independently at baseline
5) Patients receiving oral glucocorticosteroids for at least 6 months before baseline without change in dosage or dosing regimen within 3 months and having stable symptoms
6) If participating in another clinical study, at least 6 months has passed since starting this study at baseline
1) Patients with clinically apparent symptoms of cardiac failure and/or respiratory failure as determined by the investigators
2) Patients continuously using a ventilator (use of non-invasive positive-pressure ventilation [NPPV] during sleep is allowed)
3) Patients with behavior abnormalities including intellectual disability, autistic tendency, and attention deficit hyperactivity disorder that, in the opinion of the investigators, could prevent to conduct the assessment of motor function
4) Other patients as determined by the investigators to be ineligible to participate in this study
5) Patients participating in another clinical trial at baseline
80
1st name | Eri |
Middle name | |
Last name | Takeshita |
National Center Hospital, National Center of Neurology and Psychiatry (NCNP)
Department of Child Neurology
1878551
4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan
042-341-2711
erit@ncnp.go.jp
1st name | Mikiko |
Middle name | |
Last name | Shigemori |
Muscular Dystrophy Clinical Trial Network (MDCTN)
Secretariat Office
1878551
4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan
042-341-2711
shigemori@ncnp.go.jp
National Center of Neurology and Psychiatry (NCNP)
National Center of Neurology and Psychiatry (NCNP)
Self funding
pharmaceutical company
National Center of Neurology and Psychiatry (NCNP)
4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan
042-341-2711
ml_rinrijimu@ncnp.go.jp
NO
国立病院機構鈴鹿病院(三重県)
国立病院機構八雲病院(北海道)
熊本大学医学部附属病院(熊本県)
国立病院機構刀根山病院(大阪府)
国立病院機構宇多野病院(京都府)
国立病院機構東埼玉病院(埼玉県)
国立病院機構大牟田病院(福岡県)
国立病院機構医王病院(石川県)
国立病院機構長良医療センター(岐阜県)
岐阜大学医学部附属病院(岐阜県)
信州大学医学部附属病院(長野県)
東京女子医科大学病院(東京都)
兵庫医科大学病院(兵庫県)
長崎大学病院(長崎県)
名古屋市立大学病院(愛知県)
国立精神・神経医療研究センター病院(東京都)
2017 | Year | 12 | Month | 25 | Day |
Partially published
33
No longer recruiting
2017 | Year | 09 | Month | 25 | Day |
2017 | Year | 10 | Month | 06 | Day |
2018 | Year | 01 | Month | 25 | Day |
2025 | Year | 09 | Month | 30 | Day |
Prospective observational study now underway.
2017 | Year | 12 | Month | 25 | Day |
2024 | Year | 06 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034885